26
Feb
“Discovery and development of sovateltide to treat cerebral stroke patients.” Mohali: Pharmazz, Inc., a biopharmaceutical company addressing the critical care market, showcased the groundbreaking potential of its lead drug, Sovateltide in a two-day workshop on Drug Discovery and Development in New Millennium - 4 (D3NM-4) organized by the Department of Pharmacology and Toxicology, NIPER, SAS Nagar, Mohali. The chief guest of the workshop, Prof. Anil Gulati, Founder and CEO of Pharmazz, Inc. USA, delivered the keynote address on “Discovery and development of sovateltide to treat cerebral stroke patients.” Dr. Gulati discussed how he discovered this drug after an extensive 25…